101 related articles for article (PubMed ID: 2625740)
1. [Study of serum level of antithrombin-III antigen, antithrombin activity, and its ratio of AT-III-heparin complex formation in maintenance hemodialysis patients].
Yoshida K; Saka M; Kaneko Y; Kubota K; Hirao Y; Okajima E; Ishida M; Kihouin K; Motomiya Y
Nihon Jinzo Gakkai Shi; 1989 Nov; 31(11):1171-7. PubMed ID: 2625740
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
Toulon P; Jacquot C; Capron L; Frydman MO; Vignon D; Aiach M
Thromb Haemost; 1987 Jun; 57(3):263-8. PubMed ID: 3660328
[TBL] [Abstract][Full Text] [Related]
3. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
Uchida Y
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure.
Langley PG; Keays R; Hughes RD; Forbes A; Delvos U; Williams R
Hepatology; 1991 Aug; 14(2):251-6. PubMed ID: 1860682
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
[TBL] [Abstract][Full Text] [Related]
6. Functional and antigenic antithrombin III values in plasma and serum from 115 regular blood donors and antithrombin III in prediction of postoperative thrombosis.
Nilsen DW; Jeremic M; Weisert OK; Fønstelien E; Godal HC
Thromb Haemost; 1983 Aug; 50(2):530-3. PubMed ID: 6415845
[TBL] [Abstract][Full Text] [Related]
7. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of Fragmin (FR-860) in hemodialysis: multicenter cooperative study in Japan.
Suzuki T; Ota K; Naganuma S; Koshikawa S; Hirasawa Y; Nakagawa S; Otsubo O; Akizawa T
Semin Thromb Hemost; 1990 Oct; 16 Suppl():46-54. PubMed ID: 1962904
[TBL] [Abstract][Full Text] [Related]
10. Fluctuation of thrombin-antithrombin III complex in patients with acute myocardial infarction: influence of low-dose heparin administration.
Psuja P; Lewandowski K; Turowiecka Z; Zozulińska M; Tokarz A; Zawilska K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):229-36. PubMed ID: 1697824
[TBL] [Abstract][Full Text] [Related]
11. [Effect of heparin in uremic patients during hemodialysis].
Cullmann W; Glöckner WM; Müller N
Fortschr Med; 1981 Mar; 99(12):410-2. PubMed ID: 7227936
[TBL] [Abstract][Full Text] [Related]
12. Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: a cross-over study.
Naumnik B; Pawlak K; Myśliwiec M
Thromb Res; 2009 Feb; 123(4):631-6. PubMed ID: 18234290
[TBL] [Abstract][Full Text] [Related]
13. [A study of antithrombin systems during heparin therapy].
Boneu B; Immaculato F; Sie P; Caranobe C; Chamontin B; Guittard J
Nouv Presse Med; 1982 Oct; 11(41):3043-6. PubMed ID: 6183640
[TBL] [Abstract][Full Text] [Related]
14. Heparin and prostacyclin.
Camici M; Evangelisti L
Angiology; 1989 Apr; 40(4 Pt 1):294-9. PubMed ID: 2650580
[TBL] [Abstract][Full Text] [Related]
15. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
[TBL] [Abstract][Full Text] [Related]
16. Impaired vessel wall response to venous occlusion in patients with chronic renal failure on maintenance hemodialysis.
Winter M; Needham J; Mackie I; Cameron JS
Clin Nephrol; 1984 Dec; 22(6):307-13. PubMed ID: 6441660
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin III loss in patients with nephrotic syndrome or receiving continuous ambulatory peritoneal dialysis. Evidence of inactive antithrombin III in urine of patients with nephrotic syndrome.
De Stefano V; Triolo L; De Martini D; Ferrelli R; Mori R; Leone G
J Lab Clin Med; 1987 May; 109(5):550-5. PubMed ID: 3572202
[TBL] [Abstract][Full Text] [Related]
18. [Perioperative plasma antithrombin activity with "low-dose" heparin prophylaxis. Perioperatively acquired antithrombin III deficiency as a cause for the failure of heparin prophylaxis?].
Kussmann J; Hirche H; Sengupta R
Dtsch Med Wochenschr; 1983 Mar; 108(12):449-52. PubMed ID: 6832015
[TBL] [Abstract][Full Text] [Related]
19. Suppression of thrombin formation during hemodialysis with triglyceride.
Kitamoto Y; Fukui H; Matsushita K; Sato T; Soejima H; Noguchi Y; Kasama T
ASAIO J; 1993; 39(3):M581-3. PubMed ID: 8268604
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.
Clemmensen I
Thromb Haemost; 1978 Jun; 39(3):616-23. PubMed ID: 705690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]